Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05954832 · ClinicalTrials.gov registry record
A Study of Changes in Heart Function and Blood Flow in People Receiving Anesthesia
A clinical trial of Anesthesia, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT05954832: Recruiting study of Anesthesia, sponsored by Memorial Sloan Kettering Cancer Center.
NCT05954832 is a study of Anesthesia that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 250 participants, below the 109,406-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05954832, a study of Anesthesia, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand changes in heart function (how the heart pumps blood) and blood flow in people who receive general anesthesia during surgery. The researchers are particularly interested in the heart function and blood flow changes in people who experience low blood pressure (hypotension) after receiving anesthesia.
Primary Outcome
summarize the distributions of the echocardiography parameter values (pre-load LVEDd(cm), after-load LVEDs(cm), other measures \[e.g., contractility (EF %) and structural abnormalities\]) across each timepoint among patients with and without PIH
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Echocardiography
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center (All protocol activites) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-07-13 |
| Est. Completion | 2027-07 |
What NCT05954832 shows while recruiting
NCT05954832 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 109,406-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 1 intervention - of which Echocardiography is the first listed.
NCT05954832 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05954832 about?
NCT05954832 is a clinical study titled "A Study of Changes in Heart Function and Blood Flow in People Receiving Anesthesia". The purpose of this study is to understand changes in heart function (how the heart pumps blood) and blood flow in people who receive general anesthesia during surgery. The researchers are particularly interested in the heart function and blood flow changes in people who experience low blood pressur...
What is the current status of trial NCT05954832?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2023-07-13. Estimated completion is 2027-07.
What conditions does trial NCT05954832 study?
This clinical trial studies the following conditions: Anesthesia.
What interventions are being tested in trial NCT05954832?
The interventions under investigation include: Echocardiography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05954832?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05954832 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05954832's enrollment target sits among peer trials
250 10th of 57 higher than 48 of 57 other Anesthesia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
RECRUITING · Phase 4
-
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration
RECRUITING · Phase 3
-
The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes
RECRUITING
-
Oral Methadone in Cardiac Surgery
RECRUITING · Phase 4
-
Remimazolam NeuroImaging
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI